What factors would lead you to extend the duration of antithyroid drug therapy in a patient with Graves' disease who is clinically euthyroid at 12 months but has risk factors for recurrence?  

One should never discontinue methimazole after an arbitrary period of time without checking anti-TSH receptor antibody levels. If they are positive or even “normal” but not undetectable, the patient will inevitably have a recurrence of their hyperthyroidism relatively quickly (Laurberg e...

Agree with Dr. @Doria-Medina. The patients rely on our guidance for ATD, versus RAI, and rarely surgery. It is expensive for some patients to continue to have visits and tft's several times a year on ATD, compared to patients who may have post-ablative hypothyroid on stable thyroxine treatment who c...